Sanofi-aventis’ potential blockbuster Multaq (dronedarone) has been shown to reduce the risk of stroke by more than a third in patients with an irregular heartbeat. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/multaq_cuts_risk_of_stroke_by_a_third_987934The UK’s Diamond Light Source in Oxfordshire is to become the first and only place in Europe to analyse serious viruses, the results of which will be used to create new therapies to treat viral disease. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/new_uk_facility_to_analyse_serious_viruses_1004462The UK’s version of a digital archive of peer-reviewed research papers will be further developed after getting a cash injection of £1.3 million. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/uks_online_research_archive_gets_a_facelift_987837Wyeth Pharmaceuticals has pulled its European Marketing Authorisation for its drug Ellefore/Pristiq (desvenlafaxine) as a treatment of major depressive disorder. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/wyeth_pulls_europe_application_for_elleforepristiq_986594The US Food and Drug Administration has rejected Pharmaxis’ cystic fibrosis drug Bronchitol because of inadequate trial data. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/fda_turns_down_pharmaxis_cystic_fibrosis_drug_1004670Cervical cancer vaccines have been given a boost in the USA after an advisory panel there recommended approval of GlaxoSmithKline's Cervarix, while Merck & Co's Gardasil got a favourable nod to have its use extended to men - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/cervarix_recommended_for_approval_by_fda_panel_983673The new Wales Life Sciences Investment Fund has made its first investment, backing Merthyr Tydfil-based clinical research organisation Simbec Research. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/welsh_cro_accesses_new_investment_fund_1004959US Drug approvals in 2012 have reached a 15-year high with regulators giving the thumbs up to 39 new drugs. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/39_drugs_approved_in_the_usa_in_2012_1004164The growth in the global sales of generics has dived to 3.6% in 12 months – down from 11.4% in 2007, a new report says. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/sales_growth_in_generics_drops_986189Opposition to President Barack Obama’s healthcare reform plans has caused an uproar in the UK with even the British Prime Minister supporting the NHS on Twitter. - News - PharmaTimes
by Katrina Megget
www.pharmatimes.com/news/support_for_british_nhs_on_twitter_983822
